October 26, 2026

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Through a Challenging Market with a 9.45% Downside Potential

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specifically in the medical devices industry, has been a pivotal supplier of innovative solutions..

Henry Schein, Inc. (HSIC) Stock Analysis: Potential 14% Upside Amid Robust Revenue Growth

For investors eyeing the healthcare sector, Henry Schein, Inc. (NASDAQ: HSIC) presents an intriguing opportunity. With a market capitalization of $9.68 billion, this medical distribution giant..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Medical Device Market with a $4.3 Billion Valuation

Integer Holdings Corporation (NYSE: ITGR) stands as a notable player in the medical device industry, commanding a market capitalization of $4.3 billion. Headquartered in Plano, Texas,..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 37% Potential Upside Amidst Turbulent Markets

Grifols, S.A. (GRFS), a Spanish healthcare giant specializing in plasma-derived medicines, presents a compelling investment opportunity with a potential upside of 37.10%. With a market capitalization..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Uncovering a 63.64% Upside Potential

BioMarin Pharmaceutical Inc. (BMRN) stands as a prominent player in the biotechnology sector, boasting a market capitalization of $10.83 billion and a portfolio of transformative therapies..

Waystar Holding Corp. (WAY)

⚠️ No article content returned.

..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Potential 22% Upside Amidst Biotech Challenges

Sarepta Therapeutics, Inc. (SRPT) stands at a crucial juncture, balancing its pioneering work in RNA-targeted therapeutics with the financial challenges typical of the biotech sector. With..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a Remarkable 180% Potential Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA), a pioneering player in the biotechnology sector, has captured the attention of investors with its innovative approach to RNA therapeutics for..

Telix Pharmaceuticals Limited (TLX): Investor Outlook on a Biotech with 124% Potential Upside

Telix Pharmaceuticals Limited (TLX) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This Australia-based company, which specializes in therapeutic and..

Teleflex Incorporated (TFX) Stock Analysis: Unveiling a 12.99% Potential Upside in Medical Device Sector

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry, boasting a market capitalization of $5.77 billion. Headquartered..

BrightSpring Health Services (BTSG) Stock Analysis: 31.33% Upside Potential Captivates Investors

BrightSpring Health Services, Inc. (BTSG) is emerging as a notable player within the Healthcare sector, specifically in the Health Information Services industry. Based in Louisville, Kentucky,..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Navigating a 41% Potential Upside in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector, has been intriguing investors with its ambition to redefine cardiac monitoring through innovative device-based..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 64% Upside Awaits Investors

Corcept Therapeutics Incorporated (NASDAQ: CORT) is making waves in the biotechnology sector with its innovative approach to treating severe endocrinologic, oncologic, metabolic, and neurologic disorders. As..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the Diagnostics & Research Landscape with a Strong Market Presence

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing investment opportunity for those keen..

Lantheus Holdings, Inc. (LNTH) Investor Outlook: Unveiling Growth Potential with a 7.20% Upside and Robust ROE

Investors have their eyes on Lantheus Holdings, Inc. (NASDAQ: LNTH), as the company stands at a pivotal juncture within the healthcare sector. With a market capitalization..

ADMA Biologics Inc (ADMA): Analyst Consensus Reveals 59% Upside Potential for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is presenting an intriguing opportunity for investors looking to capitalize on the healthcare industry’s..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Challenging Landscape with Strategic Resilience

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal entity in the healthcare sector, specifically within the diagnostics and research industry. With a robust..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Assessing a 26.95% Potential Upside Amidst Biotech Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) is a prominent player in the biotechnology sector, making waves with its innovative approach to genetic medicines. With a market capitalization..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring an Attractive 78% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK), a key player in the biotechnology sector, commands attention with its innovative approach to muscle biology. The company, headquartered in South San..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Growth Path in a Challenging Biotechnology Landscape

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology sector, stands at a pivotal crossroads as it navigates the complexities of the healthcare industry. With..

Search

Funds

October 26, 2026

Search

Funds

October 26, 2026

FTSE 100

Funds